Ophthalmic manifestations among adults on chemotherapy at a tertiary hospital in southwestern Uganda: a cross sectional study

Abstract Background Cancer patients on chemotherapy may develop ocular manifestations—eye abnormalities, which may occur due to the cancer, or effects of cancer treatment. A majority of these patients may not have any symptoms and remain undiagnosed, only to present late with severe visual impairment or blindness. Such vision loss can interfere with cancer treatment adherence, quality of life, mental health, productivity, and safety of the patient. Ocular manifestations in a cancer patient are an important prognostic indicator, with a lower 5-year survival rate of 21.4% among those with ocular manifestations compared to 45.7% among those without. At Mbarara regional referral hospital, a tertiary teaching hospital in Uganda, routine eye screenings were not being offered to cancer patients. This study aimed to assess the ophthalmic manifestations among adult cancer patients on chemotherapy Mbarara regional referral hospital. Methods This was a hospital based descriptive cross-sectional study than included 155 randomly selected adult cancer patients on chemotherapy. The sociodemographic and medical data via structured questions. We did comprehensive eye examinations for all the study participants. We entered, cleaned and analyzed the data using STATA 17. The results were presented as descriptive statistics. Results Most participants were male (64.5%), and the median age was 57 years. The most prevalent ocular manifestations were dry eye (34.2%), cataract (31.2%), optic atrophy (9.0%), and retinopathy (8.9%). Conclusions Ocular manifestations were common among cancer patients, with dry eye, cataract, optic atrophy, and retinopathy being most frequent. We recommend routine eye screening for patients on chemotherapy.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11581069/v1
Primary Topic
Drug-Induced Ocular Toxicity
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Ophthalmic manifestations among adults on chemotherapy at a tertiary hospital in southwestern Uganda: a cross sectional study

Teddy Kwaga, Amos Twinamasiko, Moses Owiny
3 links
Research Square
Drug-Induced Ocular Toxicity
preprint

Ophthalmic manifestations among adults on chemotherapy at a tertiary hospital in southwestern Uganda: a cross sectional study

Teddy Kwaga, Amos Twinamasiko, Moses Owiny
preprint en

Abstract

Abstract Background Cancer patients on chemotherapy may develop ocular manifestations—eye abnormalities, which may occur due to the cancer, or effects of cancer treatment. A majority of these patients may not have any symptoms and remain undiagnosed, only to present late with severe visual impairment or blindness. Such vision loss can interfere with cancer treatment adherence, quality of life, mental health, productivity, and safety of the patient. Ocular manifestations in a cancer patient are an important prognostic indicator, with a lower 5-year survival rate of 21.4% among those with ocular manifestations compared to 45.7% among those without. At Mbarara regional referral hospital, a tertiary teaching hospital in Uganda, routine eye screenings were not being offered to cancer patients. This study aimed to assess the ophthalmic manifestations among adult cancer patients on chemotherapy Mbarara regional referral hospital. Methods This was a hospital based descriptive cross-sectional study than included 155 randomly selected adult cancer patients on chemotherapy. The sociodemographic and medical data via structured questions. We did comprehensive eye examinations for all the study participants. We entered, cleaned and analyzed the data using STATA 17. The results were presented as descriptive statistics. Results Most participants were male (64.5%), and the median age was 57 years. The most prevalent ocular manifestations were dry eye (34.2%), cataract (31.2%), optic atrophy (9.0%), and retinopathy (8.9%). Conclusions Ocular manifestations were common among cancer patients, with dry eye, cataract, optic atrophy, and retinopathy being most frequent. We recommend routine eye screening for patients on chemotherapy.

Research Square
Mbarara University of Science and Technology (UG), Lira University (UG)
Mbarara University of Science and Technology
Good health and well-being
Drug-Induced Ocular Toxicity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon